As of February 2022, subscribers can view and filter individual regulatory alerts per region. If you want to get our monthly compilations, visit our alerts round-up section.
26th January 2023
25th January 2023
24th January 2023
US - Federal: The Food and Drug Administration (FDA) has denied RJ Reynolds Vapor Company permission to continue selling two menthol e-cigarette products in the US. The agency issued marketing denial orders (MDOs) today against the Vuse Vibe Tank Menthol 3.0% and the Vuse Ciro Cartridge Menthol 1.5%. Brian King, director of the FDA’s Center for Tobacco Products (CTP), said: “The applications for these products did not present sufficient scientific evidence to show that the potential benefit to adult smokers outweighs the risks of youth initiation and use.”
24th January 2023
23rd January 2023
US - general: A US district judge has granted Juul Labs preliminary court approval of a $255m settlement resolving claims by consumers that it deceptively marketed e-cigarettes, Reuters reports. Judge William Orrick said the deal to settle almost 10,000 lawsuits filed by local governments across the US seemed “fair and reasonable.” He must still give final approval to the deal.
23rd January 2023
US - Oregon: House Bill 3090 has been introduced, which would ban the sale of flavoured “tobacco products”, including e-cigarettes, containing either natural or synthetic nicotine.
20th January 2023
20th January 2023
19th January 2023
US - New York: Senate Bill S2133 has been introduced. It would ban the sale of e-cigarettes that contain certain toxic metals, and require the state Department of Health to study the long-term health effects of vaping.
18th January 2023
US - Hawaii: Senate Bill 148 has been introduced, which would prohibit the sale or furnishing of a tobacco product or e-cigarette to anyone born on or after 1st January 2003.
17th January 2023
US - Montana: Bill LC 1075, which would generally revise alternative nicotine and vapour product laws relating to tobacco, is currently being drafted.
Blogs |
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.